ACET vs. QBTS
ACET (Adicet Bio, Inc.) and QBTS (D-Wave Quantum Inc) are both stocks. ACET operates in Biotechnology (Healthcare), while QBTS operates in Computer Hardware (Technology). Over the past 3 years, ACET returned -52.68%/yr vs 129.19%/yr for QBTS. At a 0.18 correlation, their price movements are largely independent.
Performance
ACET vs. QBTS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACET achieves a -6.18% return, which is significantly higher than QBTS's -16.21% return.
ACET
- 1D
- -4.24%
- 1M
- -5.16%
- YTD
- -6.18%
- 6M
- -4.90%
- 1Y
- -24.96%
- 3Y*
- -52.68%
- 5Y*
- -44.88%
- 10Y*
- —
QBTS
- 1D
- -4.66%
- 1M
- -21.24%
- YTD
- -16.21%
- 6M
- -20.39%
- 1Y
- 54.51%
- 3Y*
- 129.19%
- 5Y*
- —
- 10Y*
- —
ACET vs. QBTS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
ACET Adicet Bio, Inc. | -6.18% | -45.30% | -49.10% | -78.86% | -52.29% |
QBTS D-Wave Quantum Inc | -16.21% | 211.31% | 854.44% | -38.88% | -83.96% |
Correlation
The correlation between ACET and QBTS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Aug 8, 2022 | 0.18 |
The correlation between ACET and QBTS shifts across timeframes, from 0.18 (all time) to 0.29 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ACET:
$84.88M
QBTS:
$8.05B
ACET:
-$15.00
QBTS:
-$1.08
ACET:
0.61
QBTS:
7.16
ACET:
$0.00
QBTS:
$12.44M
ACET:
-$1.47M
QBTS:
$8.25M
ACET:
-$110.77M
QBTS:
-$399.03M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACET vs. QBTS — Risk / Return Rank
ACET
QBTS
ACET vs. QBTS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Adicet Bio, Inc. (ACET) and D-Wave Quantum Inc (QBTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACET | QBTS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.84 | ||
| Sortino ratioReturn per unit of downside risk | -1.58 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.17 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.40 | 0.77 | -1.17 |
| Martin ratioReturn relative to average drawdown | -0.59 | 1.32 | -1.91 |
Loading charts...
Drawdowns
ACET vs. QBTS - Drawdown Comparison
The maximum ACET drawdown since its inception was -99.74%, roughly equal to the maximum QBTS drawdown of -96.67%. Use the drawdown chart below to compare losses from any high point for ACET and QBTS.
Loading charts...
Drawdown Indicators
| ACET | QBTS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.74% | -96.67% | -3.07% |
Max Drawdown (1Y)Largest decline over 1 year | -63.28% | -71.01% | +7.73% |
Max Drawdown (3Y)Largest decline over 3 years | -88.93% | -79.17% | -9.76% |
Max Drawdown (5Y)Largest decline over 5 years | -98.20% | — | — |
Current DrawdownCurrent decline from peak | -99.66% | -51.07% | -48.59% |
Average DrawdownAverage peak-to-trough decline | -85.43% | -65.50% | -19.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.17% | 41.44% | +0.73% |
Volatility
ACET vs. QBTS - Volatility Comparison
The current volatility for Adicet Bio, Inc. (ACET) is 21.40%, while D-Wave Quantum Inc (QBTS) has a volatility of 30.58%. This indicates that ACET experiences smaller price fluctuations and is considered to be less risky than QBTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACET | QBTS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.40% | 30.58% | -9.18% |
Volatility (6M)Calculated over the trailing 6-month period | 49.86% | 75.04% | -25.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.53% | 109.86% | -35.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.80% | 150.72% | -59.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 93.65% | 150.72% | -57.07% |
Dividends
ACET vs. QBTS - Dividend Comparison
Neither ACET nor QBTS has paid dividends to shareholders.
Financials
ACET vs. QBTS - Financials Comparison
This section allows you to compare key financial metrics between Adicet Bio, Inc. and D-Wave Quantum Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ACET and QBTS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QBTS has higher volatility (30.58%) compared to ACET (21.40%). In terms of maximum drawdown, ACET dropped -99.74% vs QBTS's -96.67%.
QBTS currently has the higher Sharpe Ratio (0.50 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACET and QBTS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer